BD Board Declares Dividend
FRANKLIN LAKES, N.J., May 19, 2015 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 60.0 cents per common share payable on June 30, 2015 to holders of record on June 9, 2015. The indicated annual dividend rate is $2.40 per share.
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit www.bd.com.
Kristen Cardillo, Corporate Communications – 858-617-2317
Monique N. Dolecki, Investor Relations – 201-847-5378
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bd-board-declares-dividend-300086078.html
SOURCE BD (Becton, Dickinson and Company)
Released May 19, 2015